Investor Relations

Overview

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.

Investor Presentations

Stock Quote

Copyright Nasdaq. Minimum 15 minutes delayed.

Stock Chart

             

Copyright Nasdaq. Minimum 15 minutes delayed.